| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Throughout the last three months, 4 analysts have evaluated Pennant Gr (NASDAQ:PNTG), offering a diverse set of opinions from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 0 | 3 | 1 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 0 | 0 | 0 | 0 | 0 |
| 2M Ago | 0 | 2 | 1 | 0 | 0 |
| 3M Ago | 0 | 0 | 0 | 0 | 0 |
Insights from analysts' 12-month price targets are revealed, presenting an average target of $24.75, a high estimate of $26.00, and a low estimate of $23.00. Surpassing the previous average price target of $22.75, the current average has increased by 8.79%.
A clear picture of Pennant Gr's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Scott Fidel | Stephens & Co. | Maintains | Overweight | $25.00 | $25.00 |
| David Macdonald | Truist Securities | Raises | Hold | $25.00 | $22.00 |
| Ben Hendrix | RBC Capital | Raises | Outperform | $26.00 | $21.00 |
| Scott Fidel | Stephens & Co. | Maintains | Overweight | $23.00 | $23.00 |
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Pennant Gr's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
Stay up to date on Pennant Gr analyst ratings.
If you are interested in following small-cap stock news and performance you can start by tracking it here.
Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Revenue Growth: Pennant Gr's remarkable performance in 3 months is evident. As of 31 March, 2024, the company achieved an impressive revenue growth rate of 24.08%. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Health Care sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 3.13%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Pennant Gr's ROE stands out, surpassing industry averages. With an impressive ROE of 3.41%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Pennant Gr's ROA stands out, surpassing industry averages. With an impressive ROA of 0.88%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Pennant Gr's debt-to-equity ratio stands notably higher than the industry average, reaching 2.34. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in Benzinga Pro.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: PNTG
